Feb. 24 at 10:50 PM
$SLS $ABVX Just Checking - does everyone KNOW BAT, the Best Available Treatment for Control ARM Patients in the SLS Phase 3 Trial - recently FAILED 3 Large Phase 3 Trials conducted by
$ABBV? Including 2 for AML Remission Maintenance. VIALE-M, VIALE-T both Failed.
Meanwhile we are Seeing Miraculous Survival for ALL Pooled SLS P3 Patients - All Pooled: BAT arm + GPS arm.
If you don't know GPs is getting FDA Approval, you are in a rapidly dwindling minority.
- The Share Price Will Continue Climbing, Until we Get the Phase 3 Top Line Results - and then it Launches.
Gps Immunotherapy is getting the FDA Green Light to treat 100,000 AML Remission Patients - with an infinite dosing regime -
$25B TAM - Worth
$40B to Big Pharma.
